Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liangping Xia

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Frontiers in Medicine|February 10, 2025
Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancerLei Wang, Yafei You, Wenzhuo He, et al.
Oncotargets and Therapy|November 26, 2015
A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-CFangxin Liao, Wenzhuo He, Chang Jiang, et al.
Optics Express|May 15, 2013
Surface enhanced Raman scattering substrate with metallic nanogap array fabricated by etching the assembled polystyrene spheres arrayLiangping Xia, Zheng Yang, Shaoyun Yin, et al.
Clinical Breast Cancer|October 3, 2012
Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in Chinese patients with luminal A breast cancerFang Wang, Wenzhuo He, Huijuan Qiu, et al.
BMC Medicine|October 5, 2020
Adipose tissue area as a predictor for the efficacy of apatinib in platinum-resistant ovarian cancer: an exploratory imaging biomarker analysis of the AEROC trialXin Huang, Chuanbo Xie, Jie Tang, et al.
Nanotechnology|January 19, 2018
The all-optical modulator in dielectric-loaded waveguide with graphene-silicon heterojunction structureFeiying Sun, Liangping Xia, Changbin Nie, et al.
Scientific Reports|July 25, 2020
First-line cetuximab improves the efficacy of subsequent bevacizumab for RAS wild-type left-sided metastatic colorectal cancer: an observational retrospective studyShousheng Liu, Chang Jiang, Lin Yang, et al.
Oncotargets and Therapy|August 22, 2014
Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancerChenxi Yin, Chang Jiang, Fangxin Liao, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2020
Metformin selectively inhibits metastatic colorectal cancer with the <i>KRAS</i> mutation by intracellular accumulation through silencing MATE1Jinye Xie, Liangping Xia, Wei Xiang, et al.
Oncology Letters|January 25, 2019
Tumor microenvironment classification based on T-cell infiltration and PD-L1 in patients with mismatch repair-proficient and -deficient colorectal cancerShousheng Liu, Pengfei Kong, Xiaopai Wang, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Frontiers in Medicine|February 10, 2025
Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancerLei Wang, Yafei You, Wenzhuo He, et al.
Oncotargets and Therapy|November 26, 2015
A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-CFangxin Liao, Wenzhuo He, Chang Jiang, et al.
Optics Express|May 15, 2013
Surface enhanced Raman scattering substrate with metallic nanogap array fabricated by etching the assembled polystyrene spheres arrayLiangping Xia, Zheng Yang, Shaoyun Yin, et al.
Clinical Breast Cancer|October 3, 2012
Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in Chinese patients with luminal A breast cancerFang Wang, Wenzhuo He, Huijuan Qiu, et al.
BMC Medicine|October 5, 2020
Adipose tissue area as a predictor for the efficacy of apatinib in platinum-resistant ovarian cancer: an exploratory imaging biomarker analysis of the AEROC trialXin Huang, Chuanbo Xie, Jie Tang, et al.
Nanotechnology|January 19, 2018
The all-optical modulator in dielectric-loaded waveguide with graphene-silicon heterojunction structureFeiying Sun, Liangping Xia, Changbin Nie, et al.
Scientific Reports|July 25, 2020
First-line cetuximab improves the efficacy of subsequent bevacizumab for RAS wild-type left-sided metastatic colorectal cancer: an observational retrospective studyShousheng Liu, Chang Jiang, Lin Yang, et al.
Oncotargets and Therapy|August 22, 2014
Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancerChenxi Yin, Chang Jiang, Fangxin Liao, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2020
Metformin selectively inhibits metastatic colorectal cancer with the <i>KRAS</i> mutation by intracellular accumulation through silencing MATE1Jinye Xie, Liangping Xia, Wei Xiang, et al.
Oncology Letters|January 25, 2019
Tumor microenvironment classification based on T-cell infiltration and PD-L1 in patients with mismatch repair-proficient and -deficient colorectal cancerShousheng Liu, Pengfei Kong, Xiaopai Wang, et al.
Pageof 9